|
Volumn 6, Issue 2, 1999, Pages 377-391
|
Treatment of nasopharyngeal carcinoma: state of the art and new perspectives (review).
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BRACHYTHERAPY;
CLINICAL TRIAL;
COMPUTER ASSISTED RADIOTHERAPY;
HUMAN;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
NASOPHARYNX TUMOR;
PATHOLOGY;
PREDICTION AND FORECASTING;
RADIATION DOSE FRACTIONATION;
REVIEW;
SURVIVAL RATE;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
BRACHYTHERAPY;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
DOSE FRACTIONATION;
HUMANS;
NASOPHARYNGEAL NEOPLASMS;
PREDICTIVE VALUE OF TESTS;
RADIOTHERAPY, CONFORMAL;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 0033091708
PISSN: 1021335X
EISSN: None
Source Type: Journal
DOI: 10.3892/or.6.2.377 Document Type: Review |
Times cited : (13)
|
References (116)
|